KriSan Biotech will attend Bio Asia Taiwan, 2022/7/28 – 2021/7/31. Booth No.: S610
Passed “Southern Science Park Emerging Technology Application Plan”
Develop CpG1018 successfully and provide samples to the potential customers.
Passed GMP follow-up inspection by TFDA
KriSan Biotech will attend Bio Asia Taiwan, 2021/11/04 – 2021/11/07. Booth No.: R714
KriSan Biotech as a CDMO partner supplies Kg-scale of API to Atossa Genetic(NASDAQ: ATOS) from Pre-IND to Phase 2.
KriSan Biotech and OncoArendi Therapeutic (OAT) have entered into an agreement of API supply from Pre-IND to Phase 2.
Ms. Wang Yu Pei acts as President of KriSan Biotech Co., Ltd.
Congratulations!! KriSan Biotech obtained PICS/GMP certificate for pilot plant
|2018/12||KSB obtain Health Workplace certification from Ministry of Health and Welfare|
|2018/03||Deliver oncology generic API to Japan|
|2017/12||Obtain Japan Accreditation certificate of foreign drug manufacturer. Number of accreditation: AG10600073|
The Industrial Development Bureau, Taiwan Ministry of Economic Affairs(MOEA) has announced that “KriSan Biotech Co., Ltd.” is recommended as domestic pharmaceutical R & D services provider in Taiwan biotech pharmaceutical industry.